Stability and compatibility of morphine

International Journal of Pharmaceutics

Volumn 187, Issue 1, 1999, Pages 17-51

  Vermeire, A ^a   Remon, J P ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Compatibility; Morphine; Stability

Indexed keywords

ALKALOID; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; APOMORPHINE; ATRACURIUM; CEFALOTIN; DEXAMETHASONE; DIAZEPAM; DILUENT; FAMOTIDINE; FLUDARABINE; FLUOROURACIL; GLUCOSE; HALOPERIDOL; HEPARIN; KETAMINE; KETOROLAC; LEVOMEPROMAZINE; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; ONDANSETRON; PANCURONIUM; PHENOBARBITAL; RANITIDINE; SODIUM METABISULFITE; UNINDEXED DRUG; WATER;

ANALGESIA; AQUEOUS SOLUTION; CAT; DECOMPOSITION; DOG; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG INTERACTION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; GUINEA PIG; HUMAN; MOUSE; NONHUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; SOLUTION AND SOLUBILITY; TEMPERATURE;

ANALGESICS, OPIOID; ANIMALS; DRUG INCOMPATIBILITY; DRUG STABILITY; DRUG STORAGE; HUMANS; MORPHINE; SOLUTIONS;

EID: 0032831494     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00181-7     Document Type: Review

References (98)

1. Altman L., Hopkins R.J., Ahmed S., Bolton S. Stability of morphine sulfate in Cormed III (Kalex) intravenous bags. Am. J. Hosp. Pharm. 47:1990;2040-2042.
2. Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust. J. Hosp. Pharm. 25:1995;352.
3. Anderson P.M., Rogosheske J.R., Ramsay N.K.C., Weisdorf D.J. Biological activity of recombinant interleukin-2 in intravenous admixtures containing antibiotic, morphine sulfate, or total parenteral nutrient solution. Am. J. Hosp. Pharm. 49:1992;608-612.
4. Baker D.E., Yost G.S., Graig V.L., Campbell R.K. Compatibility of heparin sodium and morphine sulfate. Am J. Hosp. Pharm. 42:1985;1352-1355.
5. Baltz J.K., Kennedy P., Minor J.R., Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am. J. Hosp. Pharm. 47:1990;2075-2077.
6. Bashaw E.D., Amantea M.A., Minor J.R., Gallelli J.F. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration. Am. J. Hosp. Pharm. 45:1988;2532-2533.
7. Bray R.J., Davies P.A., Seviour J.A. The stability of preservative-free morphine in plastic syringes. Anaesthesia. 41:1986;294-295.
8. Bruera E. Ambulatory infusion devices in the continuing care of patients with advanced diseases. J. Pain Symptom Manage. 5:1990;287-296.
9. Caute B., Monsarrat B., Lazorthes Y., Cros J., Bastide R. The stability of morphine in isobaric and hyperbaric solutions in a drug delivery system. J. Pharm. Pharmacol. 40:1988;644-645.
10. Chai C., Dantalis N., Martin D, Burgess N., Somogyi A. Stability of morphine tartrate injections in plastic syringes. Aust. J. Hosp. Pharm. 24:1994;117.
11. Chandler S.W., Trissel L.A., Weinstein S.M. Combined administration of opioids with selected drugs to manage pain and other cancer symptoms-initial safety screening for compatibility. J. Pain Symptom Manage. 12:1996;168-171.
12. Colucci R.D., Cobuzzi L.E., Halphern N.A. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 45:1988;1357-1358.
13. Connors K.A., Amidon G.L., Stella V.J. Morphine. Connors K.A., Amidon G.L., Stella V.J. Chemical Stability of Pharmaceuticals. A Handbook for Pharmacists. 1986;604-611 Wiley, New York.
14. Cutie M.R. Compatibility of verapamil hydrochloride injection with commonly used additives. Am. J. Hosp. Pharm. 40:1983;1205-1207.
15. Deeks M., Davis S., Nash S. Stability of an intrathecal morphine injection formulation. Pharm. J. 30:1983;495-497.
16. DiStefano J.E., Outman W.R. Additional data on visual compatibility of foscarnet sodium with morphine sulfate. Am. J. Hosp. Pharm. 49:1992;1672.
17. Donnelly R.F., Farncombe M. Compatibility of morphine or hydromorphone with salbutamol in a syringe. Can. J. Hosp. Pharm. 47:1994;252.
18. Duafala M.E., Kleinberg M.L., Nacov C., Flora K.P., Hines J., Davis K., McDaniel A., Scott D. Stability of morphine sulfate in infusion devices and containers for intravenous administration. Am. J. Hosp. Pharm. 47:1990;143-146.
19. Ebel S., Rost D. Haltbarkeitsspezifische dünschichtchromatographische bestimmungen des morphins und seiner abbauproducte. Act. Pharm. (Weinheim). 313:1980;337-343.
20. Edwards, N.D., Reilly, C.S., 1994. Do morphine and ketamine keep? The stability of morphine and ketamine separately and combined for use as an infusion. Hosp. Pharm. Pract. Feb., 57-58.
21. Fennessy M.R., Fearn H.J. Some observations on the toxicology of morphine-N-oxide. J. Pharm. Pharmacol. 21:1969;668-673.
22. Forman J.K., Souney P.F. Visual compatibility of midazolam hydrochloride with common preoperative injectable medications. Am. J. Hosp. Pharm. 44:1987;2298-2299.
23. Forman J.K., Lachs J.R., Souney P.F. Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 44:1987;1408-1409.
24. Gila-Azanedo J.A., Mengual Sendra A., Fernandez Barral C., Testillano Tarrero M.L., Capitan Guarnizo M.J., Rubio Salvadoz M.J., Gervilla Munoz A., Garcia Martin A., Garcia Gonzalez F. Estudio de la establidad de una solucion de clorhidrato de morfina mas anestesicos locales en solucion salina 0.9 por 100 sin conservantes para uso epidural. Farm. Hosp. 18:1994;261-264.
25. Hasegawa G.R., Eder J.F. Visual compatibility of dobutamine hydrochloride with other injectable solutions. Am. J. Hosp. Pharm. 41:1984;949-951.
26. Hassan E., Leslie J., Martir-Herrero M.L. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 51:1994;2143-2145.
27. Hung C.T., Young M., Gupta P.K. Stability of morphine solutions in plastic syringes determined by reversed-phase ion-pair liquid chromatography. J. Pharm. Sci. 77:1988;719-723.
28. Hunt-Fugate A.K., Hennessey C.K., Kazarian C.M. Stability of fluconazole in injectable solutions. Am. J. Hosp. Pharm. 50:1993;1186-1187.
29. Ionescu-Matiu A., Papescu A., Moncium L. Contribution à l'étude de l'altération et de la stabilisation de la morphine et de l'apomorphine. Ann. Pharm. Franc. 6:1948;137.
30. Jay G.T., Fanikos J., Souney P.F. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection. Am. J. Hosp. Pharm. 45:1988;1556-1557.
31. Johnson C.E., Bhatt-Mehta V., Mancari S.C., McKnown J.A. Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration. Am. J. Hosp. Pharm. 51:1994;2812-2815.
32. Johnson C.E., Christen C., Perez M., Ma M. Compatibility of bupivicaine hydrochloride and morphine sulfate. Am. J. Hosp. Pharm. 54:1997;61-64.
33. Johnson C.E., Vandenbussche H.L., Chio C.C., Jacobson P.A. Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride and ceftazidime during simulated intravenous administration. Am. J. Health-Syst. Pharm. 56:1999;164-169.
34. Jones R.W., Stanko G.L., Gross H.M. Pharmaceutical compatibilities of pentothal and nembutal. Am. J. Hosp. Pharm. 18:1961;700-704.
35. Karnatz N.N., Wong J., Kesler H., Baaske D.M., Speicher E.R. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration. Am. J. Hosp. Pharm. 45:1988;368-371.
36. Kingsley Ng., Yinfoo I.R. Stability of morphine mixture with hydroxybenzoates as preservatives. Aust. J. Hosp. Pharm. 18:1988;168-170.
37. Kollo C. Mémoires présentés à la société de chimie. N°1 - Sur l'oxydation de la morphine. Bull. Soc. Chim. Romania. 1:1919;39.
38. Lam X.M., Ward C.A., DeC. Du Mée S.P.R. Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy. Am. J. Hosp. Pharm. 52:1995;1904-1909.
39. Landersjö, L., Nyhammar, E., 1987. Stability and compatibility of morphine sulphate and morphine hydrochloride in medication cassette Pharmacia, Intern rapport Pharmacia, Stockholm, Zweden.
40. Landersjö, L., Nyhammar, E., 1989. Stability and compatibility of morphine-clonidine solution in medication cassette Pharmacia, Intern rapport Pharmacia, Stockholm, Zweden.
41. Lau M.H., Hackman C., Morgan D.J. Compatibility of ketamine and morphine injections. Pain. 175:1998;389-390.
42. Le Hoang M.D., Sarbach C., Prognon P., Delvordre P., Mignot A., Pradeau D. Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leachng into morphine solutions. J. Pharm. Clin. 17:1998;35-39.
43. LeBelle M.J., Savard C., Gagnon A. Compatibility of morphine and midazolam or haloperidol in parenteral admixtures. Can. J. Hosp. Pharm. 48:1995;155-160.
44. Lichter I., Hunt E. The last 48 h of life. J. Palliat. Care. 6:1990;7-15.
45. Lor E., Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am. J. Hosp. Pharm. 47:1990;137-139.
46. Lor E., Sheybani T., Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am. J. Hosp. Pharm. 48:1991;744-746.
47. Macias J.M., Martin W.J., Lloyd C.W. Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation. Am. J. Hosp. Pharm. 42:1985;1087-1094.
48. Michelini T.J., Bhargava V.O., Dube J.E. Stability of oral morphine sulfate solution in two enteral tube feeding products. Am. J. Hosp. Pharm. 45:1988;628-630.
49. 3H]pseudomorphine in the rat. Biochem. Pharmacol. 21:1972;103-107.
50. Muhtadi F.J. Analytical profile of morphine. Florey K. Analytical Profiles of Drug Substances. 17:1988;256-366 Academic Press, San Diego, CA.
51. Nahata M.C., Morosco R.S. Stability and compatibility of anakinra with morphine sulfate and ciprofloxacin in 0.9% sodium chloride injection. Acta Pharm. 45:1995;499-502.
52. Nahata M.C., Morosco R.S., Hipple T.F. Stability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperatures. Am. J. Hosp. Pharm. 49:1992;2785-2786.
53. Neels J.T. Compatibility of bupivicaine hydrochloride with hydromorphone hydrochloride or morphine sulfate. Am. J. Hosp. Pharm. 49:1992;2149.
54. Nieves-Cordero A.L., Luciw H.M., Souney P.F. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site administration. Am. J. Hosp. Pharm. 42:1985;1108-1109.
55. Nixon A.R., O'Hare M.C., Chisakuta A.M. The stability of morphine sulphate and metoclopramide hydrochloride in various delivery presentations. Pharm. J. 254:1995;153-155.
56. Ogawa G.S. Comment on intrathecal morphine. Drug. Intell. Clin. Pharm. 18:1984;531-532.
57. Orr I., Dundee J., McBride A. Preservative free epidural morphine denatures in plastic syringe. Anaesthesia. 37:1982;352.
58. Osol, A., Hoover, J. (Eds.), Remington's Pharmaceutical Sciences, Mack Printing, Easton, 1975, 746 pp.
59. Ottesen S., Monrad L. Morfin-antiemetika-blandiger til kontinuerlig subkutan infusjon ved terminal cancer. Tiddskr. Nor. Laegeforen. 14:1992;1817-1820.
60. Oustric-Mendes A.C., Huart B., Le Hoang M.-D., Perrin-Rosset M., Pailler F.M., Darbord J.C., Prognon P., Gard C., Pradeau D. Study protocol: stability of morphine injected without preservative, delivered with a disposable infusion device. J. Clin. Pharm. Ther. 22:1997;2283-2290.
61. Parker E.A. Compatibility digest. Pentothal sodium injection. Am. J. Hosp. Pharm. 26:1969;653-654.
62. Parker W.A. Physical compatibility of ranitidine HCl with preoperative injectable medications. Can. J. Hosp. Pharm. 38:1985;160-161.
63. Pugh C.B., Pabis D.J., Rodriguez C. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 48:1991;123-125.
64. Roksvaag P.O., Fredrikson J.B., Waaler T. High-performance liquid chromatographic assay of morphine and the main degradation product pseudo-morphine. A study of pH, discoloration and degradation in 1 to 43 years old morphine injections. Pharm. Acta Helv. 55:1980;198-202.
65. Roos P.J., Glerum J.H., Meilink J.W. Stability of morphine hydrochloride in a portable pump reservoir. Pharm. Weekbl. (Sci.). 14:1992;23-26.
66. Sadjak A., Wintersteiger R. Compatibility of morphine, baclofen, floxuridine and fluorouracil in an implantable medication pump. Drug Res. 45:1995;93-98.
67. Savitsky M.E. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 47:1990;820-821.
68. Schmidt C.F., Livingston A.E. A note concerning the actions of pseudomorphine. J. Pharmacol. Exp. Ther. 47:1933;473-485.
69. Schrijvers D., Tai-Apin C., De Smet M.C., Cornil P., Vermorken J.B., Bruyneel P. Determination of compatibility and stability of drugs used in palliative care. J. Clin. Pharm. Ther. 23:1998;311-314.
70. Sitaram B.R., Tsui M., Rawicki H.B., Lam S., Courage P., Sitaram M., Chapman C.B. Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump. Int. J. Pharm. 118:1995;181-189.
71. Sitaram B.R., Tsui M., Rawicki H.B., Lam S. Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine. Int. J. Pharm. 153:1997;13-24.
72. Smythe M., Malouf E. Visual compatibility of insulin with secondary intravenous drugs in admixtures. Am. J. Hosp. Pharm. 48:1991;125-126.
73. Smythe M.A., Patel M.A., Gasloli R.A. Visual compatibility of narcotic analgesics with selected intravenous admixtures. Am. J. Hosp. Pharm. 47:1990;819-820.
74. Souney P.F., Solomon M.A., Stancher D. Visual compatibility of cimetidine hydrochloride with common preoperative injectable medications. Am. J. Hosp. Pharm. 41:1984;1840-1841.
75. Stiles M.L., Tu Y.S., Allen L.V. Stability of morphine sulfate in portable pump reservoirs during storage and simulated administration. Am. J. Hosp. Pharm. 46:1989;1404-1407.
76. Storey P., Herbert H.H., St. Louis R.H., Tarver E.E. Subcutaneous infusions for control of cancer symptoms. J. Pain Symptom Manage. 5:1990;33-41.
77. Strong M.L., Schaaf L.J., Pankaskie M.C., Robinson D.H. Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices. J. Clin. Pharm. Ther. 19:1994;361-369.
78. Targett P.L., Keefe P.A., Merridew C.G. Stability of two concentrations of morphine tartrate in 10 ml polypropylene syringes. Aust. J. Hosp. Pharm. 27:1997;452-454.
79. Travell J. A contribution to the pharmacology of pseudomorphine. J. Pharm. Exp. Ther. 34:1932;123-125.
80. Trissel L.A., Chandler S.W., Folstad J.T. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 47:1990;2525-2528.
81. Trissel L.A., Parks N.P.T., Santiago N. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives and other selected drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 48:1991;2186-2189.
82. Trissel L.A., Bready B.B., Kwan J.W., Santiago N.M. Visual compatibility of sargramostim with selected antineoplastic agents anti-infectives, or other drugs during simulated Y-site injection. Am. J. Hosp. Pharm. 49:1992;402-406.
83. Trissel L.A., Xu Q., Martinez J.F., Fox J.L. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32°C. Am. J. Hosp. Pharm. 51:1994;2138-2142.
84. Truelle-Hugon B., Tourrette G., Couineaux B., Gache-Charrette C. Study of Lavoisier morphine chlorhydrate in different active perfusion systems after reconstitution in different solvents. Ann. Pharm. Fr. 55:1997;216-223.
85. Udeani G.O., Bass J., Johnston T.P. Compatibility of oral morphine sulfate solution with enteral feeding products. Ann. Pharmacother. 28:1994;451-455.
86. Vecchio M., Walker S.E., Iazzetta J., Hardy B.G. The stability of morphine intravenous infusion solutions. Can. J. Hosp. Pharm. 41((5-9)):1988;13.
87. Vermeire A., Remon J.P. The solubility of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containers. Int. J. Pharm. 146:1997;213-223.
88. Vermeire A., Remon J.P. Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone. Int. J. Pharm. 174:1998;157-177.
89. Walker S.E., Coons C., Matte D., DeAngelis C., Iazzetta J., Kolos C., Birkhans B. Hydromorphone and morphine stability in portable infusion pump cassettes and minibags. Can. J. Hosp. Pharm. 41:1988;177-182.
90. Walker S.E., Iazzetta J., Lau D.W.C. Stability of sulfite free high potency morphine sulfate solutions in portable infusion pump cassettes. Can. J. Hosp. Pharm. 42:1989;195-200.
91. Walsh T.D., Saunders C.M. Oral morphine for relief of chronic pain from cancer. New Engl. J. Med. 305:1981;1417.
92. Wilson T.D., Forde M.D. Stability of milrinone and epinephrine, atropine sulfate, lidocaine hydrochloride, or morphine sulfate injection. Am. J. Hosp. Pharm. 47:1990;2504-2507.
93. Wulf H., Gleim M., Mignat C. The stability of mixtures of morphine hydrochloride, bupivicaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J. Pain Symptom Manage. 9:1994;308-311.
94. Xu Q.A., Trissel L.A., Martinez J.F. Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride. Ann. Pharmacother. 30:1996;756-761.
95. Yeh S.Y., Lach J.L. Stability of morphine in aqueous solutions. Am. J. Hosp. Pharm. 17:1960;101-103.
96. Yeh S.Y., Lach J. Stability of morphine in aqueous solution III Kinetics of morphine degradation in aqueous solution. J. Pharm. Sci. 50:1961;35-42.
97. Yeh S.Y., Lach J.L. Stability of morphine in aqueous solution IV: Isolation of morphine and sodium bisulfite interaction product. J. Pharm. Sci. 60:1971;793-794.
98. Zuber D.E.L. Compatibility of morphine sulfate injection and prochlorperazine edisylate injection. Am. J. Hosp. Pharm. 44:1987;67.